These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 11509905)

  • 21. In-vitro characterization of buccal iontophoresis: the case of sumatriptan succinate.
    Telò I; Tratta E; Guasconi B; Nicoli S; Pescina S; Govoni P; Santi P; Padula C
    Int J Pharm; 2016 Jun; 506(1-2):420-8. PubMed ID: 27113869
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Enhancement of the in vitro skin permeability of azidothymidine (AZT) via iontophoresis and chemical enhancer.
    Wearley L; Chien YW
    Pharm Res; 1990 Jan; 7(1):34-40. PubMed ID: 2300533
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Transscleral passive and iontophoretic transport: theory and analysis.
    Li SK; Hao J
    Expert Opin Drug Deliv; 2018 Mar; 15(3):283-299. PubMed ID: 29149574
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Controlled iontophoretic delivery of pramipexole: electrotransport kinetics in vitro and in vivo.
    Kalaria DR; Patel P; Merino V; Patravale VB; Kalia YN
    Eur J Pharm Biopharm; 2014 Sep; 88(1):56-63. PubMed ID: 24525072
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Quantitative structure-permeation relationship for iontophoretic transport across the skin.
    Mudry B; Carrupt PA; Guy RH; Delgado-Charro MB
    J Control Release; 2007 Sep; 122(2):165-72. PubMed ID: 17707106
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Characterization of convective solvent flow during iontophoresis.
    Delgado-Charro MB; Guy RH
    Pharm Res; 1994 Jul; 11(7):929-35. PubMed ID: 7937551
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Iontophoretic transport kinetics of ketorolac in vitro and in vivo: demonstrating local enhanced topical drug delivery to muscle.
    Gratieri T; Pujol-Bello E; Gelfuso GM; de Souza JG; Lopez RF; Kalia YN
    Eur J Pharm Biopharm; 2014 Feb; 86(2):219-26. PubMed ID: 23791718
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Iontophoretic drug delivery.
    Kalia YN; Naik A; Garrison J; Guy RH
    Adv Drug Deliv Rev; 2004 Mar; 56(5):619-58. PubMed ID: 15019750
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Non-invasive iontophoretic delivery of enzymatically active ribonuclease A (13.6 kDa) across intact porcine and human skins.
    Dubey S; Kalia YN
    J Control Release; 2010 Aug; 145(3):203-9. PubMed ID: 20423719
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Controlled iontophoretic transport of huperzine A across skin in vitro and in vivo: effect of delivery conditions and comparison of pharmacokinetic models.
    Kalaria DR; Patel P; Merino V; Patravale VB; Kalia YN
    Mol Pharm; 2013 Nov; 10(11):4322-9. PubMed ID: 24028565
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Transdermal iontophoretic delivery of triptorelin in vitro.
    Schuetz YB; Naik A; Guy RH; Vuaridel E; Kalia YN
    J Pharm Sci; 2005 Oct; 94(10):2175-82. PubMed ID: 16136544
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Iontophoresis: electrorepulsion and electroosmosis.
    Guy RH; Kalia YN; Delgado-Charro MB; Merino V; López A; Marro D
    J Control Release; 2000 Feb; 64(1-3):129-32. PubMed ID: 10640651
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effect of iontophoresis on in vitro transdermal absorption of almotriptan.
    Calatayud-Pascual MA; Balaguer-Fernández C; Serna-Jiménez CE; Del Rio-Sancho S; Femenía-Font A; Merino V; López-Castellano A
    Int J Pharm; 2011 Sep; 416(1):189-94. PubMed ID: 21736929
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Transport behavior of hairless mouse skin during constant current DC iontophoresis, part 2: iontophoresis of nonionic molecules with cotransport of polystyrene sulfonate oligomers.
    Liddell MR; Li SK; Higuchi WI
    J Pharm Sci; 2011 Jul; 100(7):2816-25. PubMed ID: 21455977
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Specific protein-protein interactions limit the cutaneous iontophoretic transport of interferon beta-1B and a poly-ARG interferon beta-1B analogue.
    Dubey S; Perozzo R; Scapozza L; Kalia YN
    Int J Pharm X; 2020 Dec; 2():100051. PubMed ID: 32685921
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Iontophoresis of poly-L-lysines: the role of molecular weight?
    Turner NG; Ferry L; Price M; Cullander C; Guy RH
    Pharm Res; 1997 Oct; 14(10):1322-31. PubMed ID: 9358543
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effect of the iontophoresis of a chitosan gel on doxorubicin skin penetration and cytotoxicity.
    Taveira SF; Nomizo A; Lopez RF
    J Control Release; 2009 Feb; 134(1):35-40. PubMed ID: 19047006
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Influence of asymmetric donor-receiver ion concentration upon transscleral iontophoretic transport.
    Li SK; Zhang Y; Zhu H; Higuchi WI; White HS
    J Pharm Sci; 2005 Apr; 94(4):847-60. PubMed ID: 15736190
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Capillary zone electrophoresis for the estimation of transdermal iontophoretic mobility.
    Abla N; Geiser L; Mirgaldi M; Naik A; Veuthey JL; Guy RH; Kalia YN
    J Pharm Sci; 2005 Dec; 94(12):2667-75. PubMed ID: 16258982
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Iontophoresis-mediated transdermal permeation of peptide dendrimers across human epidermis.
    Mutalik S; Parekh HS; Anissimov YG; Grice JE; Roberts MS
    Skin Pharmacol Physiol; 2013; 26(3):127-38. PubMed ID: 23549205
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.